4882
Perseus Proteomics Inc.
ペルセウスプロテオミクス
- Industry
- Pharmaceutical
- Market
- Growth
- Accounting standards
- Japanese GAAP
- Consolidation basis
- Non-consolidated
Key metrics
Revenue(thousand JPY)
Mar 2022
71,932
Mar 2023
94,201
Mar 2024
100,402
Mar 2025
120,375
Operating profit(thousand JPY)
Mar 2022
-472,195
Mar 2023
-697,769
Mar 2024
-894,729
Mar 2025
-826,430
Operating profit margin(%)
Mar 2022
-656.45
Mar 2023
-740.72
Mar 2024
-891.15
Mar 2025
-686.55
Profit before tax(thousand JPY)
Mar 2022
-597,096
Mar 2023
-785,072
Mar 2024
-1,102,533
Mar 2025
-902,340
Profit(thousand JPY)
Mar 2022
-599,023
Mar 2023
-786,999
Mar 2024
-1,104,460
Mar 2025
-904,800
Total assets(thousand JPY)
Mar 2022
3,300,530
Mar 2023
2,566,650
Mar 2024
1,693,810
Mar 2025
1,818,837
Cash and cash equivalents(thousand JPY)
Mar 2022
3,214,852
Mar 2023
2,444,934
Mar 2024
1,541,419
Mar 2025
1,667,921
Cash flows from operating activities(thousand JPY)
Mar 2022
-476,842
Mar 2023
-564,274
Mar 2024
-833,898
Mar 2025
-719,485
Cash flows from investing activities(thousand JPY)
Mar 2022
-33,868
Mar 2023
-212,989
Mar 2024
-150,343
Mar 2025
-75,157
Cash flows from financing activities(thousand JPY)
Mar 2022
2,647,548
Mar 2023
-20
Mar 2024
63,943
Mar 2025
923,381
Return on equity(-)
Mar 2022
-
Mar 2023
-
Mar 2024
-
Mar 2025
-
Equity ratio(%)
Mar 2022
95.5
Mar 2023
92.15
Mar 2024
78.18
Mar 2025
74.4
Earnings per share(JPY per share)
Mar 2022
-54.47
Mar 2023
-66.93
Mar 2024
-93.69
Mar 2025
-63.41
Net assets per share(JPY per share)
Mar 2022
268.05
Mar 2023
201.13
Mar 2024
110.94
Mar 2025
91.74
Dividend per share(-)
Mar 2022
-
Mar 2023
-
Mar 2024
-
Mar 2025
-
Payout ratio(-)
Mar 2022
-
Mar 2023
-
Mar 2024
-
Mar 2025
-
Disclaimer
The financial information and metrics on this page are based on publicly available filings and other public sources. We do not guarantee their accuracy, completeness, or timeliness.
The information on this page is provided for reference purposes only and does not constitute a recommendation to buy or sell any security. Investment decisions should be made at your own responsibility.